Alzheimer’s disease and Parkinson’s disease are two of the most commonly discussed neurodegenerative diseases that affect the elderly population. Alzheimer’s is a progressive degenerative brain disorder that affects memory, thinking, behavior and other cognitive functions, whereas Parkinson’s affects the nervous system, causing difficulty with movement, including trembling, difficulty walking and trembling. The exact cause of Alzheimer’s and Parkinson’s diseases is not known, although genetics and environmental factors are thought to play roles in their development. In particular, research has shown that Alzheimer’s is likely passed on through familial history, and environmental factors, such as highly toxic exposure, are connected to cases of Parkinson’s. Other medical conditions such as diabetes, high blood pressure, and high cholesterol, have been found to increase the risk of developing either Alzheimer’s or Parkinson’s. Though the causes of these diseases are not yet fully understood, scientists are continuing to investigate potential treatments and preventive measures. For Alzheimer’s, current treatments aim to slow down the progression of the disease, while those for Parkinson’s have focused on alleviating symptoms. Scientists have also been looking into ways of preventing and delaying the onset of both diseases. The Alzheimer’s Association has currently identified risk reduction strategies, which include healthier eating, exercise, mental stimulation, and proper management of medical conditions such as hypertension and diabetes. As medical technology advances, more research is being conducted to better understand Alzheimer’s and Parkinson’s diseases, and to find possible treatments for them. Both diseases share many of the same risk factors, and progress differently for each individual.
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)